The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Industry at a Glance
Industry Ranking
78 / 470
Overall Ranking
141 / 4721
Industry
Software & IT Services
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
7
analysts
Buy
Current Rating
19.000
Target Price
+6.86%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 47.52% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 92.13M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 75.81.
Undervalued
The company’s latest PE is -35.26, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 14.95M shares, decreasing 32.91% quarter-over-quarter.
OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.